Pathology lab

Driving diagnostic certainty for life-changing decisions in pathology.


two lab pathologists exchange smiles - the pathologist in focus is reviewing images of stained tissue sections on her computer

Advancing science, breaking barriers, and building the future

Empowering your pathology lab to reach its full potential

At Roche, we are personally committed to driving diagnostic certainty for life-changing decisions in pathology. We do this by advancing science to improve patients’ lives, and by delivering innovative solutions that break down the barriers anatomic pathology labs face every day. This empowers our customers to reach their full potential now, and build a future that holds the potential to beat cancer.

Drawing on a deep understanding of anatomic pathology, we deliver a well-integrated, end-to-end solution that advances clinical decision-making in oncology. We keep our customers at the forefront through continuous improvements in staining automation, lab integration, and digitization while pushing the boundaries of medical science to provide high medical value with the most comprehensive assay portfolio available today.

Pathology lab power button

Committed to eliminating the burden of cancer

At Roche, we believe beating cancer begins in the lab, with the right answer, for the right patient, at the right time. We have a clear vision for a future where people anywhere in the world can harness the power of high-quality, reliable diagnostics that clinicians need to provide the highest standard of care.

This drives our commitment to ongoing innovations that redefine the standard of care and bring us closer to our goal of defeating cancer.

Automated instrumentation for timely, reliable, and reproducible results.

The BenchMark ULTRA PLUS system’s fully-automated workflow for slide staining improves turnaround time and decreases touchpoints.
Optimize efficiency and stain quality with the automated VENTANA HE 600 pathology laboratory staining system.
The BenchMark Special Stains system automatically stains histology specimens with reagents for in vitro diagnostics, enhancing workflow with proven technology.

Break down lab barriers with connected and integrated instrumentation and software.

The navify® Pathology Lab Advantage solution supports support workflow automation within the anatomical pathology laboratory through:1) Tracking and specimen chain of custody throughout the life of a sample.2) Improved patient safety by reducing errors and minimizing the risk of mislabeling, positive patient identification, and single- piece flow.3) State-of-the-art informatics and business intelligence.4) Promoting productivity and a lean workflow.
navify® Pathology Lab Hub delivers a solution which provides universal LIS connectivity for Roche's product portfolio and competitors’ products used in Anatomic Pathology laboratories. navify® Pathology Lab Hub may be used in histology and/or cytology and/or molecular labs. navify® Pathology Lab Hub addresses the connectivity needs of Roche's customers by providing a single interface point for all data routing between LIS systems and their product portfolio, and by routing data without manipulation or changes to the message content.The intended use of navify® Pathology Lab Hub is the following:Connect laboratories' LIS system(s) and product portfolio through a single middlewareReceive order information from the customer’s LIS system and route this to appropriate productsRoute data/information (status updates, reports, analysis data, etc.) back to the customers’ LIS system(s)Route data within Roche customers’ product portfolioThe different types of information are listed below.TypeDescriptionPatientData about a patient such as name, surname, date of birth, gender, contact, relationship with their cases...CaseData about thecase such as number, date of registration, demographic, relationship with their specimens, host identifier that has called the case...ContainerThe sample is allocated in the container. Some of the fields are the identification of the specimen, the location of the sample, the sample type (organ, tissue, mass, biopsy, liquid,...), relationship with their blocks,...SpecimenTissue sample held in a container.BlockThe block contains a piece of tissue to be evaluated. Some of the fields are the identification of the block or cassette, their status (marked, verified, embedded), relationship with their slides,...SlideIt contains one of the cuts which has been made from the sample. Some of the fields are the identification of the slide, the orientation of the cut, the stain protocol performed, its status (printed, staining, stained, assembled), location of pictures that have been done on the slide.Types of information processed through navify® Pathology Lab Hub.
The navify® Analytics for Pathology Lab makes use of data that has been aggregated and prepared by navify® Analytics platform to provide operational insights for customers with navify® Pathology Lab Advantage Workflow Solutions in laboratories, including but not limited to:Object volumesStain volumesSender volumesCompleted/pending case countsTurnaround timeAverage slides/caseIdentification of quality issue typesDashboards, calculations, and data display methods are subject to change.The dashboards available to an individual user are based on the user's defined role. Multi-site dashboards provide aggregated visualizations of multiple laboratories. Single- site dashboards provide visualizations of an individual laboratory.

Taking labs further on their journey to impact patients' lives with the industry's most robust menu of reliable, ready-to-use assays across a multitude of disease areas.

VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail is intended for the qualitative detection of Kappa mRNA and Lambda mRNA in formalin-fixed, paraffin-embedded (FFPE) human bone marrow and lymphoid tissue stained on a BenchMark IHC/ISH instrument using chromogenic in situ hybridization (ISH) and visualized using light microscopy. VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail is intended as an aid in the identification of B-cell lymphomas and plasma cell neoplasms.Results of the assay should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.This product is intended for in vitro diagnostic (IVD) use.
Roche Cell Collection Medium is designed for the preservation and transport of cells to be used in molecular testing and/or for the preparation of cytology slides.

Driving diagnostic certainty for life-changing decisions in precision oncology with the broadest menu of companion diagnostic tests available today.1

VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx - Building on the same proven technology of the widely adopted HER2 (4B5) assay, Roche has delivered the only test approved to identify HER2-low breast cancer patients - helping match even more women with highly effective personalised therapies.
VENTANA PD-L1 (SP263) Assay is intended for the qualitative detection of the programmed death ligand 1 (PD-L1) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC), urothelial carcinoma (UC) and other tumor tissues stained with OptiView DAB IHC Detection Kit on a BenchMark IHC/ISH instrument.

Solving tomorrow’s problems, today.

The DISCOVERY ULTRA Research Staining System is intended to automatically stain histological or cytological specimens on microscope slides with specific immunohistochemistry or in situ hybridization reagents for research use only. Evolved from the DISCOVERY series of instruments, the DISCOVERY ULTRA instrument fully automates the processes of baking, deparaffinization, and staining.

Benefits of pathology lab solutions from Roche

Amplify your impact on patient outcomes with high medical value solutions

Our commitment to high medical value innovation ensures that laboratories benefit from a leading-edge test menu across several disease areas, including the gold standard in breast diagnostics.1 We offer the most comprehensive menu of ready-to-use immunohistochemistry/in situ hybridization (IHC/ISH) assays, including the most companion diagnostic tests available today2 to link diagnoses with therapeutic options that can lead to better outcomes for patients.

Each of the 200+ assays in our extensive menu is built with clinical utility in mind. We uphold rigorous scientific standards throughout the development process to ensure you have robust and reliable products in your hands to help maximize your impact on patients’ lives.

This dedication to innovation, diversity, and quality underscores our mission to empower healthcare providers with state-of-the-art solutions across our pathology portfolio.

  • Over two decades of experience developing predictive diagnostics
  • Companion diagnostics that offer access to 17 personalized therapies on label and counting
  • An estimated 3.5 million patients tested with our HER2, ALK, and PD-L1 companion diagnostic tests annually*3

Optimize and grow your pathology lab business with solutions built with you in mind

We consistently explore new opportunities to help you break down barriers to success through continuous improvements in staining automation, integrated workflow solutions, digitization, and AI-based clinical decision support.

We have the clinical expertise, innovation mindset, and customer focus to deliver end-to-end digital solutions that support the laboratory’s workflow, from staining to digital imaging to AI-based clinical decision support that drives diagnostic certainty.

In addition, expert Roche personnel support your educational and technical needs to ensure successful setup, implementation, day-to-day operations, and troubleshooting of our solutions – so you can enjoy peace of mind and freedom to focus on the high-value tasks that can make a day’s work more rewarding.

Partner with the largest investor in new and sustainable solutions4 that change healthcare standards

As the industry leader in diagnostic research and development, we remain the foremost investor in innovations that positively impact lives and shape the future.4

Renowned for our commitment to developing products that enhance lives while prioritizing environmental responsibility, we are also dedicated to assisting laboratories in achieving their sustainability objectives and staying ahead of evolving compliance standards. Roche is proud to stand as one of the world's top three sustainable healthcare companies in the Dow Jones Sustainability Index (DJSI).5

Laboratory technician at work in the laboratory.

Online pathology education portal: Empower your practice

We support pathologists with resources to stay up-to-date on emerging biomarkers and technologies that are rapidly evolving the field of pathology. Our team has developed a variety of tools to elevate your knowledge and confidence in results. Advance your practice with educational content and interactive training to aid in the interpretation of our assays.

Pathologist in a lab is sitting at a microscope and is about to analyze a stained tissue slide

Pathology webinars from industry thought leaders

Engage with Roche and industry experts with our curated series of innovative webinars, hosted on BrightTALK. Presented by Roche Diagnostics, these educational live webinars feature insights from key opinion leaders on the latest and most relevant topics in pathology and precision medicine. Join the ongoing conversation in these rapidly evolving areas of healthcare.

Contact us

Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.

*Estimated number of unique patients tested based on total 2022 sales volume

References

  1. NordiQC. (2020). Nordic Immunohistochemical Quality Control, HER2 run B30 2020
  2. Data on file. Roche Diagnostics International Ltd.
  3. Data on file. Roche Diagnostics International Ltd.
  4. Fierce Biotech. [Internet; cited 2024 Jun 18]. Available from: https://www.fiercebiotech.com/biotech/top-10-pharma-rd-budgets-2022
  5. GlobeNewswire. [Internet; cited 2024 Jun 18]. Available from: https://www.globenewswire.com/news-release/2023/12/15/2796818/0/en/Roche-named-among-top-three-most-sustainable-healthcare-companies-in-the-Dow-Jones-Sustainability-Indices.html